Personal profile
Expertises
Cancer Immunotherapy
Treatment of Metastatic Melanoma
Main research areas
Cancer Immunotherapy
Current research
Novel Immune Resistance Mechanisms
Potential conflicts of interest
None
Fingerprint
Dive into the research topics where Marco Donia is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Cell Therapies and Bispecific Engagers: Redefining Strategies Against Checkpoint Resistance
Läubli, H., König, D., Donia, M., Binder, M. & Zippelius, A., 15 Apr 2026, In: Clinical Cancer Research. 32, 8, p. 1397-1410 14 p.Research output: Contribution to journal › Review › peer-review
-
Controversies in upper gastrointestinal cancers: adoptive cell therapies
Donia, M., Mansoor, W. & Valpione, S., Mar 2026, In: ESMO Gastrointestinal Oncology. 11, 100306.Research output: Contribution to journal › Journal article › Research › peer-review
-
Dabrafenib plus trametinib vs encorafenib plus binimetinib in BRAF-mutant metastatic melanoma: a real-world propensity score-matched survival analysis
Garitaonaindia, Y., Khan, S., Friis, R., Kjær, S., Borch, T. H., Ruhlmann, C., Guldbrandt, L. M., Luczak, A. A., Schmidt, H., Bastholt, L., Svane, I. M., Donia, M. & Ellebaek, E., 1 Feb 2026, In: JNCI-Journal of the National Cancer Institute. 118, 2, p. 261-268 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Discontinuation of BRAF/MEK inhibitor therapy after long-lasting response: Clinical outcomes in advanced melanoma
Døssing, R. H., Hesselberg, E., Clausen, A. B., Luczak, A. A., Presti, M., Svane, I. M., Schmidt, H., Bastholt, L., Donia, M. & Ellebaek, E., 5 Feb 2026, In: European Journal of Cancer. 234, 8 p., 116200.Research output: Contribution to journal › Journal article › Research › peer-review
-
Dynamics of checkpoint receptors in γδ T cell subsets are associated with clinical response during anti-PD-1 immunotherapies
Catafal-Tardos, E., Dachicourt, L., Baglioni, M. V., Fares da Silva, M. G. F., Secci, D., Donia, M., Kverneland, A. H., Svane, I. M. & Bekiaris, V., Jan 2026, In: EMBO Molecular Medicine. 18, 1, p. 91-119 29 p.Research output: Contribution to journal › Journal article › Research › peer-review